


| Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets |
|
Abpro to receive up to $1.1 billion, including a $30 million upfront equity investment, clinical funding, milestones, and royalties Abpro grants exclusive license to Abpro Bio , formerly named Ugint Co. Ltd , to develop and commercialize ABP-100 and ABP-201 in Asian markets, including Greater China, Japan, and South Korea.
Posted: 2020-03-03 06:40:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.